SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Releases

2016 :: 2015  ::  2014 :: 2013 ::  2012 ::  2011 :: 2010

Total Artificial Heart Recipient Heads Home for the Holidays with New Donor Heart & Kidney

Last month, with the holiday season just around the corner, Jennifer Kliesing was preparing to give her husband the ultimate gift: one of her kidneys. In June, her husband Jeremiah had suffered two heart attacks and was subsequently implanted with the SynCardia temporary Total Artificial Heart at Texas Heart Institute (THI) at St. Luke's Episcopal Hospital in Houston. When Jeremiah's kidney function had not returned after several months, Jennifer had been tested and approved as a match for her husband. However, on Nov. 11, a matching donor heart and kidney became available, and Jeremiah received the dual transplant he had been waiting for...

Continue Reading

Forbes Names SynCardia One of "America's Most Promising Companies"

SynCardia Systems, Inc., the privately-held manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, has been selected by Forbes as one of "America's Most Promising Companies." The list features 100 privately held up-and-comers with compelling business models, strong management teams, notable customers, strategic partners and precious investment capital. Ranked No. 77, SynCardia was the only Arizona company to make the cut...

Continue Reading

SynCardia Forms European Entity to Address Growing Demand for World's Only Approved Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today it has formed SynCardia Systems Europe GmbH in Bad Oeynhausen, Germany, to address growing demand for the SynCardia temporary Total Artificial Heart in the European market. SynCardia GmbH will be led by Managing Directors Oliver Voigt, PhD and Markus Leinberger, RN...

Continue Reading

1st Findings on Exercise Performance with SynCardia's Total Artificial Heart Published in The Journal of Heart and Lung Transplantation

In the November issue of The Journal of Heart and Lung Transplantation (JHLT), Virginia Commonwealth University (VCU) Medical Center in Richmond published the first findings demonstrating that physical exercise and measurable rehabilitation are feasible with the SynCardia temporary Total Artificial Heart...

Continue Reading

SynCardia Honored with Membership in World Technology Network

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that it has been inducted into the World Technology Network (WTN) as a new Corporate Member. Membership can only occur through the annual Awards process, in which individuals and companies are selected via the judgment of the current WTN Fellows. SynCardia was selected as one of 6 finalists for the 2011 World Technology Award in Health & Medicine, presented in association with TIME, Fortune, CNN, Science/AAAS and Technology Review...

Continue Reading

SynCardia Named "Arizona Bioscience Company of the Year"

On Oct. 13, SynCardia Systems, Inc., manufacturer of the world's only FDA, Health Canada and CE approved Total Artificial Heart, was named "Arizona Bioscience Company of the Year" by the Arizona BioIndustry Association (AZBio)...

Continue Reading

Texas Heart Institute Implants 4 SynCardia Total Artificial Hearts in 12 Days

SynCardia Systems, Inc., manufacturer of the world's only FDA, Health Canada and CE approved Total Artificial Heart, announced today that Texas Heart Institute (THI) at St. Luke's Episcopal Hospital (SLEH) in Houston performed four implants of the SynCardia temporary Total Artificial Heart over a 12-day period beginning July 22...

Continue Reading

Total Artificial Heart Patient Enjoys Spotlight as "The Only Man in Turkey Who Lives Without a Heart"

In May 2011, Omer Bayrak made headlines when he became the first patient in Turkey to be discharged from the hospital using the Freedom® portable driver to power his SynCardia temporary Total Artificial Heart. Since returning home to wait for a matching donor heart, Mr. Bayrak has been enjoying his new-found celebrity as "the only man in Turkey who lives without a heart"...

Continue Reading

SynCardia's Total Artificial Heart Rescues LVAD Patient with Right Ventricular Failure

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University Hospital of Nantes successfully transplanted 51-year-old Total Artificial Heart patient Louise Mouche after 177 days of support. Mrs. Mouche is a French gypsy who lives with a sedentary group of people approximately 40 km from Nantes....

Continue Reading

SynCardia Selected as Finalist for 2011 World Technology Award

SynCardia Systems, Inc., manufacturer of the world's only FDA, Health Canada and CE approved Total Artificial Heart, announced today that it has been selected as a finalist for the 2011 World Technology Award for Health & Medicine. The award, which honors those doing "innovative work of the greatest likely long-term significance" in science, technology and related fields, is presented by the World Technology Network (WTN) in association with TIME, Fortune, CNN, Science/AAAS and Technology Review...

Continue Reading

1st Pediatric Total Artificial Heart Patient Discharged Home Using Freedom® Portable Driver

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Texas Children's Hospital in Houston has discharged its first pediatric Total Artificial Heart patient to wait for a matching donor heart at home. On Aug. 31, 18-year-old Jordan Merecka left the hospital using the Freedom® portable driver, a wearable power supply for his Total Artificial Heart...

Continue Reading

SynCardia Goes Social on Facebook, Twitter and LinkedIn

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that it has launched company pages on Facebook, Twitter and LinkedIn in order to educate a larger audience about the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart. There have been more than 950 implants of the Total Artificial Heart, accounting for more than 230 patient years of life on the device...

Continue Reading

University of Iowa Discharges 1st Total Artificial Heart Patient in the Midwest

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University of Iowa Hospitals and Clinics has discharged the first Total Artificial Heart patient in the Midwest to wait for a matching donor heart at home using a portable power supply called the Freedom® driver. Richard Whittington, 59, received the Total Artificial Heart on July 6 and after 34 days was discharged from the hospital on Aug. 9...

Continue Reading

University of Münster Bridges 1st Patient to Transplant with SynCardia's Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University of Münster in Germany has successfully bridged its first patient to transplant with the Total Artificial Heart after 89 days of support...

Continue Reading

UK's 1st Total Artificial Heart Patient Discharged Home Using Freedom® Portable Driver

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that on Aug. 2, Papworth Hospital in Cambridge discharged the United Kingdom's first Total Artificial Heart patient to wait for a matching donor heart at home with his wife and 5-year-old son using the Freedom® portable driver...

Continue Reading

University of Iowa Implants State's 1st SynCardia Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that University of Iowa Hospitals and Clinics - the only comprehensive academic medical center in Iowa - has performed the state's first implant of the Total Artificial Heart...

Continue Reading

1st Clinical Experience Using Freedom® Portable Driver to Power SynCardia's Total Artificial Heart Published in Journal of Heart and Lung Transplantation

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart (TAH-t), announced today that an article reporting the first use of the Freedom® portable driver with a Total Artificial Heart patient was published in the July issue of the Journal of Heart and Lung Transplantation...

Continue Reading

Texas Children's Hospital Implants Its 1st SynCardia Total Artificial Heart to Save 17-Year-Old Suffering from Biventricular Heart Failure

SynCardia Systems, Inc. announced today that Texas Children's Hospital in Houston performed its first implant of the SynCardia temporary Total Artificial Heart on May 22, to save the life of 17-year-old Jordan Merecka. Texas Children's is the first pediatric hospital in the world to implant SynCardia's Total Artificial Heart...

Continue Reading

Dr. Marvin Slepian Presents on SynCardia's Total Artificial Heart and Freedom® Portable Driver at TechConnect World Summit

On June 14, Marvin J. Slepian, M.D., Professor of Medicine (Cardiology and Biomedical Engineering) at the University of Arizona and co-founder and chairman of SynCardia Systems, Inc., presented on the SynCardia temporary Total Artificial Heart during his keynote address at the TechConnect World Summit held in Boston...

Continue Reading

1st Turkish Total Artificial Heart Patient Discharged Using Freedom® Portable Driver

SynCardia Systems, Inc. manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Florence Nightingale Hospital in Istanbul has discharged Turkey's first Total Artificial Heart patient to wait for a matching donor heart at home using the Freedom® portable driver. Weighing 13.5 pounds, the Freedom driver is the world's first wearable portable driver designed to power SynCardia's Total Artificial Heart both inside and outside the hospital...

Continue Reading

40 New Hospitals Join SynCardia's Certification Program to Implant Total Artificial Heart During Past Year

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that during the past year, 40 hospitals have enrolled in SynCardia's Certification Program to implant the world's only FDA, Health Canada and CE approved Total Artificial Heart...

Continue Reading

Female Army Veteran Gets Second Chance at Life with SynCardia's Total Artificial Heart After Being Referred to Hospice Care

In 1992, Army veteran Margaret Daugherty, then 22, was blessed with a donor heart. Following the transplant, she was able to return to a normal, healthy life for 18½ years. However, in December 2010, Margaret was admitted to the local VA hospital in Lexington, Ky, her donor heart barely functioning. She had received a pacemaker that August, but her condition had continued to deteriorate...

Continue Reading

Russia Transplants 1st SynCardia Total Artificial Heart Patient after 238 Days

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that the Bakoulev Scientific Center for Cardiovascular Surgery (BSCCS) in Moscow successfully bridged Russia's first Total Artificial Heart patient to transplant after 238 days of support...

Continue Reading

Michael Garippa Announced as SynCardia's New CEO

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Rodger Ford, the company's CEO for the past six years, has stepped down. SynCardia President Michael Garippa has taken over as CEO in addition to his current role. Mr. Ford is joining MicroMed Cardiovascular, Inc. manufacturer of the HeartAssist 5™ left ventricular assist device, as CEO and Chairman of the Board...

Continue Reading

SynCardia Recognizes 7 Certified Centers for Use of Total Artificial Heart and Freedom® Portable Driver

On April 13, SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, presented awards to seven SynCardia Certified Centers during its Clinical Investigator meeting in San Diego for its FDA-approved Investigational Device Exemption (IDE) clinical study of the Freedom® portable driver. The 13.5 lb Freedom driver, which is also CE approved for use in Europe, is the world's first wearable driver designed to power the Total Artificial Heart both inside and outside the hospital...

Continue Reading

BBC's Flagship Science TV Series "Horizon" Features Patient with SynCardia's Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that the BBC's flagship science series, "Horizon," is airing an episode that includes a segment featuring a Total Artificial Heart patient waiting at home for a matching donor heart using the Freedom® portable driver...

Continue Reading

After 832 Days, San Camillo Hospital Transplants 1st Total Artificial Heart Patient

On April 2, San Camillo Hospital in Rome discharged its first patient to be bridged to transplant with SynCardia's Total Artificial Heart. On Feb. 23, after 832 days of life with the Total Artificial Heart, Giuseppe Nicotera received the heart transplant he'd been waiting more than two years for...

Continue Reading

SynCardia Posts Best Q1 in Company History

SynCardia Systems, Inc., the privately-held manufacturer of the SynCardia temporary Total Artificial Heart, announced today that it set a new Q1 record in 2011, nearly doubling sales from its previous best Q1 in 2010...

Continue Reading

Largest Private Hospital in Turkey Performs 1st Implant of SynCardia's Total Artificial Heart

On March 21, Florence Nightingale Hospital in Istanbul, Turkey, performed its first implant of SynCardia's Total Artificial Heart...

Continue Reading

Dr. Marvin Slepian Publishes 8-Page Article on SynCardia's Total Artificial Heart in U.S. Cardiology

SynCardia Systems, Inc. announced today that the company's Chairman and Chief Scientific Officer, Marvin J. Slepian, MD, has published an eight-page article in the spring issue of U.S. Cardiology, titled "The SynCardia Temporary Total Artificial Heart—Evolving Clinical Role and Future Status"...

Continue Reading

Cedars-Sinai Medical Center Begins Certification to Implant SynCardia's Total Artificial Heart

SynCardia Systems, Inc. announced today that the 13-member multi-disciplinary team from Cedars-Sinai Heart Institute will become the first in Los Angeles to complete certification to implant the SynCardia temporary Total Artificial Heart. During 2010, Cedars-Sinai performed the most heart transplants, 75, of all the 116 U.S. medical centers that performed adult heart transplants...

Continue Reading

#1 Health TV Show on Public Broadcasting Produces 30-Minute Program on the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. announced today that the longest running health and wellness series on public television, "Healthy Body, Healthy Mind" has produced a 30-minute program featuring the world's first and only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart...

Continue Reading

Texas Children's is First Pediatric Hospital to Begin Certification Process for SynCardia's Total Artificial Heart

Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The hospital intends to use the Total Artificial Heart as a bridge to transplant for their patients who received a heart transplant as children and now require mechanical support as a bridge to their second transplant...

Continue Reading

1st U.S. Female Patient Discharged with Total Artificial Heart Powered by the Freedom® Portable Driver

On Jan. 20, Marcela Padilla, 21, became the first woman and the fifth person in the U.S. to leave the hospital using the Freedom® portable driver to power her SynCardia temporary Total Artificial Heart. The Tucson mom was discharged from University Medical Center (UMC) just in time to celebrate her 21st birthday at home with her husband and 9-month-old son Santiago...

Continue Reading

Fast Company Magazine Names SynCardia #20 Among World's 50 Most Innovative Companies

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that it has been named No. 20 in Fast Company's annual list of the world's Most Innovative Companies. Described as a "rising newcomer," SynCardia joins major brands including Apple, Twitter, Google and Intel in Fast Company's Top 50...

Continue Reading

1st Australian Total Artificial Heart Patient Bridged to Transplant

On Dec. 23, 2010, St. Vincent's Hospital in Sydney, Australia, successfully bridged its first patient to transplant with the SynCardia temporary Total Artificial Heart after 127 days of support. This patient was only the second person in the Southern Hemisphere to receive the Total Artificial Heart...

Continue Reading

1st U.S. Total Artificial Heart Patient Discharged Home Using Freedom® Driver Receives Dual Transplant

On Jan. 15, after 864 days of life with the SynCardia temporary Total Artificial Heart, Charles Okeke received a dual heart and kidney transplant at Mayo Clinic Hospital in Phoenix. Okeke made headlines in May 2010 when he became the first Total Artificial Heart patient in U.S. history to leave the hospital without a human heart. Okeke was able to return home as part of an FDA-approved Investigational Device Exemption (IDE) clinical study of the 13.5 lb Freedom® portable driver...

Continue Reading

1st Hospital in UK Begins Certification to Implant SynCardia's Total Artificial Heart

On Feb. 7, the surgical team from Papworth Hospital in Cambridge, United Kingdom, led by Dr. Steven Tsui, Consultant Surgeon & Director of Transplantation, will complete the first of four phases of certification to implant the SynCardia temporary Total Artificial Heart. Papworth is the 66th hospital in the world and the first hospital in the UK to begin certification for the Total Artificial Heart...

Continue Reading

Four New Hospitals Begin Certification for SynCardia's Total Artificial Heart

On Jan. 20, SynCardia Systems, Inc. announced that four new hospitals, two in Turkey and two in the U.S., have begun certification to implant the SynCardia temporary Total Artificial Heart as a bridge to transplant. The four centers have, or will complete the first of four phases of certification during the month of January...

Continue Reading

VCU Medical Center Performs 900th Implant Worldwide of SynCardia’s Total Artificial Heart

On Dec. 28, 2010, Virginia Commonwealth University Medical Center (VCU) performed the 900th implant worldwide of the SynCardia temporary Total Artificial Heart...

Continue Reading

Search offcanvas